- Home
- TNXP vs CLPT Comparison
TNXP vs CLPT Comparison
Compare TNXP & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- CLPT
- Stock Information
- Founded
- TNXP 2007
- CLPT 1998
- Country
- TNXP United States
- CLPT United States
- Employees
- TNXP N/A
- CLPT N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- TNXP Health Care
- CLPT Health Care
- Exchange
- TNXP Nasdaq
- CLPT Nasdaq
- Market Cap
- TNXP 335.6M
- CLPT 318.4M
- IPO Year
- TNXP N/A
- CLPT N/A
- Fundamental
- Price
- TNXP $22.41
- CLPT $29.60
- Analyst Decision
- TNXP Buy
- CLPT Strong Buy
- Analyst Count
- TNXP 1
- CLPT 3
- Target Price
- TNXP $70.00
- CLPT $27.67
- AVG Volume (30 Days)
- TNXP 1.1M
- CLPT 1.6M
- Earning Date
- TNXP 11-11-2025
- CLPT 11-06-2025
- Dividend Yield
- TNXP N/A
- CLPT N/A
- EPS Growth
- TNXP N/A
- CLPT N/A
- EPS
- TNXP N/A
- CLPT N/A
- Revenue
- TNXP $9,831,000.00
- CLPT $33,593,000.00
- Revenue This Year
- TNXP $14.79
- CLPT $22.34
- Revenue Next Year
- TNXP $933.49
- CLPT $25.50
- P/E Ratio
- TNXP N/A
- CLPT N/A
- Revenue Growth
- TNXP N/A
- CLPT 19.68
- 52 Week Low
- TNXP $6.76
- CLPT $9.76
- 52 Week High
- TNXP $130.00
- CLPT $29.80
- Technical
- Relative Strength Index (RSI)
- TNXP 30.44
- CLPT 81.01
- Support Level
- TNXP $23.60
- CLPT $24.21
- Resistance Level
- TNXP $29.19
- CLPT $28.73
- Average True Range (ATR)
- TNXP 1.63
- CLPT 2.11
- MACD
- TNXP 0.12
- CLPT 0.93
- Stochastic Oscillator
- TNXP 5.31
- CLPT 84.70
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.